It is critically important to understand and predict fluid transport within both physiological and pathological tissues in order to develop effective treatment strategies.
Computational Model 131
Our computational framework is compartmentalised into two models. The first predicts 132 blood flow through the tumour vasculature and the second predicts interstitial fluid flow 133 throughout the cancerous tissue through use of Green's functions. Our method enables 134 application to whole, large vascular networks (> 2 cm 3 with > 10 5 blood vessels), 135 thereby permitting predictions of whole tumour fluid dynamics which incorporate the 136 inherent architectural heterogeneities occurring at the micron-scale. 137 The intravascular component incorporates the model of Pries et al. [42] to simulate 138 vascular blood flow, where the structural properties of the segmented tumour networks 139
and haemodynamic parameters are used as inputs. Flow or pressure boundary 140 conditions at all terminal nodes in the vascular network are required to predict blood 141 flow throughout the network. These boundary data are very challenging to measure in 142 vivo, so we deploy the flow estimation algorithm of Fry et al. [39] , to estimate boundary 143 data based on the assumption that the microcirculation is regulated in response to 144 haemodynamics stimuli relating to flow and shear stresses [43] . The scheme estimates sensitivity is weighted towards the definition of these two target parameters. This 150 enables physiologically realistic blood pressure and flow distributions to be estimated 151 across an entire vascular network and has been applied to breast tumour [44] , colorectal 152 December 24, 2018 7/36 tumours [38] , cortex [45] , glioma [38] and skeletal muscle [46] . 153 The second component to our computational model describes fluid transport 154 through the porous interstitium using a Darcy model, coupled to the vascular flow 155 solution via Starling's law which describes fluid transport across the endothelium. The 156 vasculature is represented by a discrete set of points sources of flux where the source 157 strengths are defined by the vascular blood flow solution. A similar approach has been 158 applied to simulate O 2 transport across various tissues [40, 45, 47] . Our approach 159 enables us to explore the effect of vascular architecture heterogeneity on fluid transport 160 within the interstitium for large-scale vascular networks.
161
The following sections detail the mathematics behind our model along with its 162 computational implementation for large vascular networks. We detail the assignment of 163 model parameters and boundary conditions for application of our model to tumour 164 networks.
165
Vascular Blood Flow

166
The segmented tumour networks consist of a series of vessel segments connected by 167 nodal junctions or, in the case of boundary nodes, one-segment nodes which form a 168 boundary to the microvascular network (see Fig 1 b ). We define a positive flow 169 direction from the start node to end node of each vessel segment. Under the assumption 170
of Poiseuille flow and conserving flow at blood vessel junctions, the relationship between 171 nodal pressures, p k and the boundary boundary fluxes Q 0i is given by
where N is the set of all nodes, I is the set of all interior nodes and B is the set of all 173 boundary nodes with known boundary conditions. For all interior nodes, conservation of 174 flux at vessel junctions dictates that Q 0i = 0, however, if i is a known boundary node, 175 Q 0i is the inflow (or outflow if negative).
176
Following the notation of Fry et al. [39] , the matrix K ik represents network
where S is the set of all segments,
and
is the matrix of vessel conductances where l j , d j and µ j denote the length, diameter 181 and effective blood viscosity of segment j, respectively.
182
We apply empirical in vivo blood viscosity laws, which prescribe the effective blood 183 viscosity as a function of vessel diameter and haematocrit, to compute µ j and 184 consequently incorporate non-Newtonian effects in each individual microvessel [48] .
185
Network haematocrit heterogeneity plays an important part in network flow resistance. 186
However, in this study, we set network haematocrit to 0.45 as we do not have sufficient 187
data to parametrise a haematocrit model at this scale. With future availability of 188 appropriate data, the model has the flexibility to incorporate haematocrit 189 heterogeneity [49] . 190 In the absence of measured flow and pressure data at network boundaries, further 191 assumptions are required to obtain a unique solution. The method proposed by Fry et 192 al. [39] sought to solve a constrained optimisation problem, formulated in terms of a 193 Lagrangian objective function defined by
Here, p 0k is the target pressure at node k, τ j is the wall shear stress in segment j, τ 0j is 195 the corresponding target shear stress, k p and k τ are weighting factors associated with 196 the pressure and shear deviations from the target values, λ i is the Lagrange multiplier 197 associated with node i and w k is the vessel length associated with node k. Setting dL/dp i = 0 and combing with (1) yields a sparse linear system with unknowns p k and 199 λ i . Assigning a pressure drop to a proportion of boundary nodes forms a well-posed 200 system which can be solved using standard methods [39] .
201
The blood flow estimation model by Fry et al. [39] has been thoroughly tested using 202 mesenteric networks [50] in which blood flow measurements were taken in individual 203 vessels and used to inform parameter estimation [39, 42, 48, 51] . Darcy's law has been effectively used to describe the passage of fluids [3, 14, [30] [31] [32] [33] 52] or 206 solutes [40, 45] through tissues. In this study, we use Darcy's law to describe the 207 relationship between the volume-averaged IFP, p, and interstitial fluid velocity (IFV), u, 208 within the porous interstitial domain:
where κ is the hydraulic conductivity of the interstitial tissue. Here we assume that 210 interstitial pressure tends towards a constant value, p ∞ , in the far-field region,
Tumours are leaky due to large pores along a vessel's lumen, and so the vasculature 212 exhibits a strong fluid and oncotic interaction. Following the approach of Baxter and transport across the endothelium:
wall, respectively, S is the surface area of the vasculature, σ is the oncotic reflection 217 coefficient and, ∆p and ∆Π are the fluid and oncotic pressure gradients between the 218 vasculature and tissue.
219
The tumour vascular architecture is used to spatially parametrise the locations of a 220 discrete set of sources of flux into the interstitial domain. Assuming these sources both 221 supply or drain the interstitium, conservation of mass yields
where x j and φ j are the spatial coordinates and strength, respectively, of point source j, 223
of fluid flux from the vasculature to the surrounding interstitial domain.
225
Applying the substitutionp = p − p ∞ , the Green's function, G(x, x * ), for the adjoint problem forp is given by
For source a given source, we distribute the delta function over a sphere of finite 226 radius, r 0 . This allows the corresponding Green's function to be described as a radially 227 symmetric function:
We distribute a total of N s sources across the vasculature with spacing λ i , and assign a source radii, r 0i , equal to the corresponding blood vessel radius (see Fig 1 c ).
Using Green's superposition principle for linear operators, the convolution of G provides 231 the corresponding pressure solution for source i ∈ N s and so
where q s j is the vector of source strengths. Here, G ij is the Green's function associated 233 with (10) and defined by
where r ij is the distance between sources, defined as r ij = |x i − x j |, and κ i is the 235 interstitial hydraulic conductivity at the location of source i.
236
From (6), the Green's function, G ij , can be used to calculate the volume-averaged 237 IFV, given by
where
Starling's law, (8) , can be rearranged into the form
where p v,i (calculated by (12) ) and Π v,i are the blood and oncotic plasma pressure at 241 the vessel wall, p b,i (calculated by (5)) and Π b,i are the vascular blood pressure at 242 source i, in the absence of diffusive interstitial fluid transfer, and oncotic fluid pressure, 243
and J v,i is the rate of fluid flow per unit volume from blood vessel i to the interstitium. 244
The intravascular resistance to fluid transport across blood vessel i, is defined by where S i and L p,i is the surface area and vascular conductance of vessel i, respectively. 246
Integrating over the volume of vessel i and assuming flux at the interface is 247 continuous, flux at the interface is defined by
where r v,i is the vessel radius and l i is the length of vessel i.
249
Equations (12), (16) and (18) are then combined to give a set of N s equations to be 250 solved for the source fluxes q s j ,
Prescribing parameter values (see subsequently, tissue IFP and IFV fields can be computed using (12) and (14), 257 respectively (see Fig 1 d ). required. An outline of the interaction between the biomedical imaging, and vascular 268 and interstitial flow compartments is given in Fig 1 d .
269
The computational framework was coded using C++ [55] and run on a Apple Mac 270 Pro, with 2 × 3.06 GHz 6-Core Intel Xeon processor and 64 GB of RAM. The system (19) was used solved using a biconjugate gradient method [56] and implemented using the Armadillo sparse linear algebra library [57] . to peritumoural vessels [44, 58] , we developed an optimisation procedure which assigns 279 vascular pressures to tumour surface vessels, based on a target pressure drop, with 280 iterative adjustments to match in vivo measurements of mean perfusion from ASL-MRI 281 (see Fig 2 a, b) . These in vivo data are acquired for the same tumours that were 282 subsequently subjected to OPT analysis. Using this approach, we are able to ensure 283 good agreement between in silico predictions and measured perfusion data [38] .
284
In this study a vascular pressure of 30 or 20 mmHg for the GL261 and 45 or 15 285 mmHg for the LS147T tumour was randomly assigned to 5% of surface boundary nodes, 286
in order to meet the required tissue perfusion. To ensure randomness, the peritumoural 287 nodes were represented by a list. The elements in the list were rearranged randomly 288 using a uniform random number generator where the system clock was used to seed the 289 random number engine. The nodes located in the top 5% of the list were then randomly 290 assigned a low or high pressure use an equivalent randomised approach. was designed so that values at opposing ends of the pressure spectrum could not be located within a defined vicinity of each other. This "exclusion region", centred on a given boundary node, was defined as an ellipsoid volume with diameters, along its three 297 principal axes, equal to 5% of the tissue dimensions.
298
A proportion of boundary nodes are contained within the tumour volume as a 299 consequence of either angiogenesis which form blind-end vessels, or artefacts of OPT.
300
Previous studies approximated the fraction of blind-end vessels in sample MCa -IV 301 carcinomas to be 33% [59] . However, blind-end information is not available for either 302 GL261 or LS147T tumours. Therefore, consistent with previous computational 303 studies [44] , blind-ends were randomly applied to 33% of remaining boundary nodes 304 (using the previous randomised approach), with the remaining 62% of boundary nodes 305 left as unknown in the flow optimisation scheme of Fry et al. [39] . pressure gradients. We identify the centre of the tumour and duplicate the hull, which is 323 then expanded to form a 10 µm gap between the two surfaces (see Fig 2 d ). IFP is then 324 calculated across all nodal points on each surface, each paired by a vector normal to the 325 opposing surface. A pressure gradient is then computed along each normal vector and 326 the corresponding velocities are calculated. 3) A sphere packing algorithm is applied to 327 the nodes on the original tumour hull, whereby no sphere overlaps neighbouring spheres 328 (see Fig 2 e ). Any inflowing node (defined by the corresponding pressure gradient) is 329 averaged across the great circle of its corresponding sphere and its contribution is 330 summed together to calculate the interstitial component of tissue perfusion. Total tissue 331 perfusion is calculated by summing over the peritumoural vascular inlets and interstitial 332 perfusion values. 333 Finally, we prescribe baseline parameter values (see Table 2 ). We assume that the 334 tumours were isolated in subcutaneous tissue in the absence of lymphatics, therefore the 335 far-field pressure, p ∞ , was set to 0 mmHg. Due to a lack of experimental data, the 336 vascular conductance and interstitial conductivity, L p and κ, respectively, were given 337 uniform values based on literature (2.8 × 10 −7 cm mmHg -1 s -1 and 1.7 × 10 −7 338 cm 2 mmHg -1 s -1 , respectively [31, 63] ). As the transport of blood plasma proteins is not 339 modelled explicitly in our model, we assume a constant oncotic pressure gradient of 5 340 mmHg between the vasculature and interstitium.
341
Results
342
In the following section we apply our computational framework to a GL261 orthotopic 343 murine glioma and a LS147T human colorectal carcinoma xenograft to form baseline 344 flow solutions. We then explore sensitivity to source parameters, which include source 345 distribution, source radii and bilateral communication between the vascular and 346 interstitial compartments. We then perform sensitivity analysis to the interstitial 347 parameters (for example, vascular hydraulic conductance and interstitial hydraulic conductivity) on IFP and IFP profiles in the LS147T tumour. We also provide an example of changes occurred by parameter variation in fluid dynamic spatial maps. Our vascular flow simulations are in good agreement with those in 353 computational [44, 64] and experimental literature (see Table 3 and Fig 3) . To test the 354 variability induced by our stochastic boundary condition implementation, the 355 optimisation procedure (detailed in Fig 2 a, b ) was repeated for a total of n = 12 for restricted to the outer rim of the tumours [65] . The mean standard deviation of vascular 360 blood pressures across all simulations was low with values of 0.82 and 1.53 mmHg (with 361 maxima of 4.78 and 13.2 mmHg) for GL261 and LS147T, respectively (see Fig 5 a, e ). 362
The elevated standard deviations in vascular pressure were located at the periphery of 363 the tumours, which is to be expected as the high and low vascular pressures were 364 stochastically assigned here. Furthermore, our mean blood velocity and vessel wall shear 365 stresses agree with similar numerical modelling of vascular blood flow in the 366 MDA-MB-231 breast cancer cell line [44] . respectively. This implies that imposing physiologically realistic pressure boundary 371 conditions generates physiologically realistic perfusion, and consequently accurate drug 372 delivery solutions [38] .
preserving the IFP gradient (see Fig 6 b ). This is an intuitive result since we held the 465 oncotic pressure gradient constant across the entire vasculature, therefore any increase 466 in σ resulted in systematic reduction in both IFP and IFV (see Fig 6 b , f). tumour tissue [11] . Similarly to σ, a reduction in L p resulted in decreasing IFP across 471 the tumour but with contrasting regional gradients (see Fig 6 c ). Our analysis showed 472 that with decreasing L p , IFP tended towards the assigned far-field pressure due to decreasing fluid filtration from the vasculature, and so in its limit, the IFP would uniformly be equal to p ∞ . This is due to decreasing fluid filtration, indicating that the 475 model produces a physiologically viable response. In comparison, a reduction in L p 476 induced minimal changes to IFV in the core of the tumour but resulted in decreases 477 towards the periphery (see Fig 6 g ).
478
Variations in the interstitial conductivity, κ, ranged from 1.33 × 10 −11 to 1.04 × 10 −6 479 cm 2 /mmHg s. In this case, we established that sensitivity to this parameter are Simulations predicted a steeper IFP gradient across the tumour. This is contrary to 498 previous studies [67, 68] , where IFP was found to reduce when tumour vasculature was 499 normalised. However, these studies normalised the vasculature uniformly across the 500 tumour, and our equivalent sensitivity analysis for uniform changes in L p observed a 501 similar IFP response (see Fig 6 c ).
502
In response to changes in IFP, our model predicted elevated tumour interstitial fluid 503 speed (IFS -see Fig 7 a ), a similar result to [68] who observed that advection is dominant at small pore sizes in two-dimensions. Steeper IFP gradients also increased perfusion and outward facing IFV streamlines (see Figs 4 b and 7 b).
506
Considering our predicted IFP responses for uniform and radially varying vascular 507 normalisation, we hypothesise that for vascular normalisation therapy to effectively 508 reduce to IFP, blood vessels across the tumour need to be normalised. Further, that if 509 vascular normalisation increases macromolecular drug penetration via the vasculature to 510 the core, outward interstitial advective currents may inhibit the effectiveness of such 511 therapies once delivered to the interstitium. However, these effects need to be explored 512 using a comprehensive model to detail the delivery of normalisation therapies, and 513 consequently macromolecular drug delivery. In addition, the effect of normalisation is 514 likely to be dependent on tumour architectural properties, such as vascular density and 515 interstitial hydraulic conductivity, and so requires study across a range of tumours with 516 spatially varying conductivities. significantly alter the IFP distribution across the tumour, with increased IFP occurring 595 at the tumour periphery, compared to baseline. Variation in the oncotic pressure 596 contribution, by modifying the oncotic reflection coefficient, only affected the 597 magnitude of the interstitial pressure, with minor changes to the IFP and IFV profiles, 598 similar to those reported in previous studies [3] . Increasing L p and κ, raised the 599 gradient of the interstitial pressure profile, thereby increasing fluid transport through 600 the interstitium. However, our IFP distributions did not reach 0 mmHg at the periphery 601 of the tumours as in previous studies [3, 14, 67] . We hypothesise that this is due to not 602 applying a fixed pressure at the tumour boundary in our model, which results in a 603 smoother transition of IFP to the surrounding tissue, similar to previous computational 604 modelling of tumour vascular heterogeneity [35, 36] . 605 We finally performed a feasibility study detailing how our framework can be used to 606 investigate cancer therapies, such as vascular normalisation. We modified vascular 607 hydraulic conductances and oncotic reflection coefficients in a linear radially varying 608 fashion in the LS147T network. Values ranged from those associated with tumours at 609 its core, to physiological tissue levels at its periphery. Our model predicted that IFP at 610 the core was slightly elevated, and that a pressure gradient is formed radially across the 611 tumour core which causes raised, outwardly directed interstitial flow. Consequently, we 612 predict that vascular normalisation therapies need to uniformly normalise a tumour to 613 lower tumour IFP, and that ineffective normalisation could reduce the efficacy of drug 614 therapies. These results are preliminary, and require further analysis and application to 615 further LS147T (and other cell-line) datasets. However, they indicate that modifying, or 616 normalising, the parameters in our computational framework is a simple and effective 617 way of investigating the fluid dynamic properties, such as interstitial pressures and 618 velocities, associated with an individual tumour. Moreover, our framework predicts 619 spatial maps of flow across three-dimensional cancerous tissue, enabling flow 620 heterogeneities induced by realistic vascular networks to be quantified for subsequent in 621 silico investigations into anti-cancer therapies.
622
Our results and proposed computational framework offer significant scope for future 623 expansion. Current limitations include, for example, our stochastic approach to 624 simulating vascular blood flow which was implemented due to the in-availability of 625 experimental data. Recent in vivo methods provide a step forward in approximating conditions by discerning global tumour pressure gradients through observations of tissue 627 fluid velocity [26] , which could lead to greater accuracy when assigning boundary 628 conditions specific to a tumour. Similarly, parameter values such as the vascular 629 conductance and interstitial hydraulic conductivity were assigned using previous 630 literature values since these tissue-specific measurements can be challenging to procure 631 through experimentation. For example, interstitial conductivity values across normal 632 tissue have been reported to span four orders of magnitude [17] . Future work could seek 633 to predict spatially heterogeneous maps of interstitial hydraulic conductivity using 634 REANIMATE and new experimental data [26] . 635 There are also opportunities to expand the computational model to incorporate more 636 complex biological phenomena. For example, our model does not currently incorporate 637 tumour compression of vessels due to increasing shear stresses within the tumour, a 638 critical property of understanding angiogenic vasculature [29, 69] . In addition, our model 639 does not explicitly incorporate necrotic regions within cancerous tissues. Yet necrotic 640 regions can influence interstitial fluid delivery [3, 14] and tumour macromolecular 641 transport [52] , and so are vital to incorporate if our computational framework. 642 We expect to find a wide utility for REANIMATE in a range of disease areas, 643 particularly given the current interest in optical clearing methods and their widespread 644 use in biomedical research. REANIMATE is novel and timely and will find extensive 645 use for hypothesis testing, to enable tumour biology and drug delivery to be better 646 understood, which in turn may enable the next generation of cancer therapies. 
